Abstract
A new sensitive and specific method using liquid chromatography/tandem mass spectrometry for determination of bryostatin 1 was developed and validated. Sample pretreatment involved a double liquid-liquid extraction step with a mixture of acetonitrile/n-butyl chloride (1/4, v/v). Separation of the compound of interest, including the internal standard paclitaxel, was achieved on a Waters X-Terra C18 (50 × 2.1 mm i.d., 3.5 μm) analytical column with acetonitrile/water mobile phase (80:20, v/v) containing 0.1% formic acid using isocratic flow at 0.15 mL/min for 13 min. The analytes of interest were monitored by tandem mass spectrometry with electrospray positive ionization. The linear calibration curves were generated over the range of 50-2000 pg/mL with values for the coefficient of determination of >0.99. The values for both within-day and between-day precision and accuracy were <15%. This method was used to characterize the plasma pharmacokinetics of bryostatin 1 at doses of 20 μg/m2 to optimize treatment with this agent.
Original language | English (US) |
---|---|
Pages (from-to) | 143-148 |
Number of pages | 6 |
Journal | Analytical biochemistry |
Volume | 337 |
Issue number | 1 |
DOIs | |
State | Published - Feb 1 2005 |
Keywords
- Bryostatin 1
- LC/MS/MS
- Pharmacokinetics
ASJC Scopus subject areas
- Biophysics
- Biochemistry
- Molecular Biology
- Cell Biology